EVFM - Evofem partners with a360 Media to support Phexxi prescription growth
- Evofem Biosciences ( NASDAQ: EVFM ) is up 6.3% premarket after the firm entered in a pact with a360 Media.
- The pact with a360 Media delivers Phexxi branded content in leading entertainment and lifestyle magazines and websites in the U.S.
- a360 Media's brands include US magazine, InTouch Weekly, and Woman's World.
-
After the first two weeks of the partnership, there was 16% lift in new Phexxi prescriptions.
For further details see:
Evofem partners with a360 Media to support Phexxi prescription growth